Skip to main content
Search
Toggle navigation
Hauptnavigation
About
Untermenü für „About“
Vision and Mission
About us
Untermenü für „About us“
GÖG
PPRI
PPI
WHO CC
Team
News
Contact
Expertise
Untermenü für „Expertise“
Pharmaceutical policies
Untermenü für „Pharmaceutical policies“
Pharmaceutical systems research
Pharmaceutical policy analysis
Ongoing pharmaceutical research and analysis projects
Medicine prices
Untermenü für „Medicine prices“
Legal Mandate
Pharma Price Information (PPI)
European medicine price database (EURIPID)
Research, technical support and trainings
International collaborations
Untermenü für „International collaborations“
PPRI networks
Scientific collaborations
Further collaborations
Medical devices
Untermenü für „Medical devices“
Study supporting the monitoring of availability of medical devices on the EU market
Study on the implementation of Article 17 of Regulation (EU) 2017/745 on medical devices on the EU market
Services
Untermenü für „Services“
Medicine price data
Research
Training
Policy advice
Methodology
Supporting networks
Publications
Untermenü für „Publications“
Studies and analyses
Untermenü für „Studies and analyses“
Articles
Technical reports
Books/book chapters
Working papers
Published abstracts
Posters
PPRI country information
Untermenü für „PPRI country information“
PPRI Profiles / Briefs
PPRI Posters
Methodology documents
Further reading
Glossary
Untermenü für „Glossary“
About Glossary and translations
Online search
Events
DE
Untermenü für „DE“
Wofür wir uns einsetzen
PPRI
Unsere Schwerpunkte
Untermenü für „Unsere Schwerpunkte“
Arzneimittelpolitik
Arzneimittelpreisvergleiche und -analysen
Internationale Vernetzung und Kooperation
Medizinprodukte
Publikationen
Glossar
Veranstaltungen
News
ES
Untermenü für „ES“
Acerca de nosotros
PPRI
Nuestra área de expertís
Untermenü für „Nuestra área de expertís“
Políticas farmacéuticas
Análisis y comparación de precios en medicamentos
Cooperación y trabajo en red internacional
Dispositivos médicos
Publicaciones
Glosario
Eventos
Noticias
RU
Untermenü für „RU“
О нас
PPRI
Наша компетенция
Untermenü für „Наша компетенция“
Исследование систем лекарственного обеспечения
Анализ лекарственной политики
Анализ и сравнение цен на лекарственные средства
Международная сеть и сотрудничество
Изделия медицинского назначения
Публикации
Глоссарий
Мероприятия
Новости
Members
x
close
Glossary
A
|
B
|
C
|
D
|
E
|
F
|
G
|
H
|
I
|
L
|
M
|
N
|
O
|
P
|
Q
|
R
|
S
|
T
|
U
|
V
|
W
C
Conditional marketing authorisation
A conditional marketing authorisation may be granted where, although comprehensive clinical data referring to the safety and efficacy of the…
Conditional Pricing
to be added in German: Bedingungsabhängige Preisbildung Methode der Preisbildung, bei welcher der Preis eines Arzneimittels an bestimmte…
Conditional treatment continuation (CTC)
Continuation of coverage for individual patients is conditioned upon meeting short-term treatment goals. Cf. managed entry agreements
Consignment
The quantity of a pharmaceutical(s), made by one manufacturer and supplied at one time in response to a particular request or order. A consignment…
Consumption
Use of services and supplies. Consumption in health care is commonly examined in terms of pattern of use of a single service (e.g. number of visits…
Consumption-based reimbursement
The level of reimbursement depends on the expenses for medicines of a patient within a certain period of time (increasing reimbursement with rising…
Container
The material employed in the packaging of a pharmaceutical product. Containers include primary, secondary and transportation containers. Containers…
Continuity of care
Defined as the degree to which a series of discrete healthcare events is experienced as coherent and connected and consistent with the patient’s…
Cost, insurance and freight (CIF)
The cargo insurance and delivery of goods to the named port of destination (discharge) at the seller's expense. Buyer is responsible for the import…
Cost-benefit analysis
Compares the cost of a medicinal intervention to its benefit. Both costs and benefits must be measured in the same monetary units (e.g. euro, dollars…
Cost-containment
Measures taken to reduce expenditure or the growth rate of expenditure, or the unit cost of services. Cost-containment measures may be targeted to…
Cost-effectiveness
Value for money. A specific health care treatment is said to be “cost-effective” if it gives a greater health gain than could be achieved by using…
Cost-effectiveness analysis (CEA)
Cost-effectiveness analysis (CEA) is an economic analysis that assesses both the costs and the effects of a health intervention. Costs are measured…
Cost-free medicines
Cost-free medicines are products which are given to hospitals/hospital pharmacies in the course of the delivery without need for payment (e.g. from…
Cost-plus pricing
Pricing policy that takes into account production costs, promotional expenses, research & development, administration costs, overheads and a…
Cost-sharing and/or risk-sharing
A provision of health insurance or third party payment that requires the individual who is covered to pay part of the cost of health care received.…
Counterfeit medical product
The term counterfeit medical product describes a product with a false representation of its identity and/or Source. This applies to the product, its…
Coverage
A measure of the extent to which the services rendered cover the potential need for those services in the community. Last update: 7 June 2023…
Coverage with evidence development (CED)
A binary coverage decision is conditioned upon the collection of additional population level evidence to support continues, expanded, or withdrawal…
D
De-listing (Delisting)
Exclusion of a medicine from a medicine list (e.g. positive list), often resulting in exclusion from reimbursement. In German: Delisting /…
Pagination
First page
« First
Previous page
‹‹
Page
1
Page
2
Current page
3
Page
4
Page
5
Page
6
Page
7
Page
8
Page
9
…
Next page
››
Last page
Last »